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1. Introduction  
Autism spectrum disorders are currently formally diagnosed after pursuing two levels of 
investigation (Blackwell, 2001; Filipek et al., 1999, 2000). The first consists of monitoring the 
child’s development and specific autism signal detection, which implies parent and physician 
attention, while the second involves actual diagnosis and evaluation, performed by specialized 
medical staff. Both levels of diagnosis rely on the careful observation of specific changes in 
child development, concerning movement, discovery and interaction with objects and people, 
games and language, which exhibit atypical variations in autism spectrum disorders. 
Intelligence tests, which aim to be a conventional estimate for the severity of mental 
retardation that may accompany autism, can serve as a relatively suitable approximation. 
There are many specific tests to diagnose autism, none ubiquously applied, and the final 
diagnosis depends on an overall estimation of brain function and, to a great extent, on the 
competence of the diagnostician. Therefore, the evaluation of a clinical diagnosis of autism 
through paraclinical methods – whether imaging, functional or laboratory work (metabolic, 
immunological, cytogenetic or molecular tests) – that would justify a medical conclusion, 
represents a necessity that is still unattainable. For autism spectrum disorders no specific 
paraclinical methods have as yet been identified, despite serious efforts invested. Traditional 
medicine was overcome in discriminate between different patients, thus opening the door for 
interdisciplinary studies which developed into new sciences, like psychoneuroendocrinology, 
psychoneuroimmunology and their corresponding insertions in genetics. 
Over the years, some of the elements suspected to be involved in causing autism spectrum 
disorders were studied, providing mixed results. The present study will list converging 
results, and will attempt to portray autism from the perspective of modern investigation 
methods. 
2. Neuroimaging 
Imaging methods, from the classic X-ray to the CT-scan (computerized axial tomography), 
the PET (positron emission tomography), the SPECT (simple proton emission computerized 
tomography) and the MRI (magnetic resonance imaging), along with their functional 
variations – fMRI (functional Magnetic Resonance Imaging), sMRI (structural MRI), MEG 
(magnetoencephalography), DTI (diffusion-tensor tracking) – aim to highlight anatomical 
and physiological modifications in the central nervous system and associate them with 
autism spectrum disorders via physical or physiological parameter evaluations. 
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Imaging is useful in diagnosing autism first of all by measuring brain component 
dimensions because in most autistic children, MRI studies showed a particular dynamics of 
brain and cranium development. Development peaks occur between 2 and 5 years of age, 
when cranial circumferences are above average and cerebral volume increases, and are 
followed, in adolescent and adult ages, by reduced cerebral dimension and function 
(Aylward et al., 2002; Courchesne et al., 2010; Hazlett et al., 2011). The evaluation and 
monitoring of child development dynamics may be performed using WHO Anthro software 
(World Health Organization-WHO, 2011), made in accordance with WHO standards (WHO, 
2007) for children aged between 0 and 5. For children above 5, statistical data is available 
from the Centers for Disease Control and Prevention – USA (Kuczmarski et al., 2002). 
An in-depth and detailed analysis of the brain revealed some anomalies in component 
dimensions and especially in the ratio of white to grey matter: the corpus callosum is 
diminished (Frazier & Hardan, 2009; Just et al., 2007); the frontal lobes are enlarged due to 
an excess of white matter (Cheng et al., 2010); the temporal lobes have a reduced grey matter 
content; the cerebellum has an over 30% excess of white matter (Carper et al., 2002; 
Courchesne et al., 2010). Microscopical post-mortem imagery revealed Purkinje cell loss in the 
cerebellum. These particular cells are selectively vulnerable to hypoxia, ischemia, G-protein 
dysfunctions, viral infections, heavy metals, as well as to a wide range of metabolites and 
chemicals (Kern & Jones, 2006). Histological studies also showed numerical reductions in 
amygdala axons (Schumann & Amaral, 2006) and reduced cell sizes in the hippocampus, 
similar to what is seen in the case of a precocious maturation (Bauman & Kemper, 2005). The 
two cerebral formations are involved in emotional and memory process development, two 
aspects typically targeted by autism spectrum disorders (Kleinhans et al., 2009; Saitoh et al., 
2001). The use of MRI-DTI for the  microstructural analysis of pathways interconnecting 
hippocampus and amygdala with the mid-fusiform gyrus in the temporal lobe (which 
participates in number, word, color and physiognomy recognition) revealed 
dysfunctionalities of these connections in autistic subjects which took a face recognition test 
(Conturo et al., 2008). The cause for this diminished response to stimuli was considered to 
be the reduction of axon diameters as a result of hypermielinisation, which yields a lower 
neuron conduction speed. Hippocampus and amygdala dimensions, which vary with the 
age and functionality of the investigated subjects, suggest the incongruence of cerebral 
components in the developmental dynamics.  
A disharmonious development, a reduced corpus callosum volume and a small quantity of 
grey matter might justify the reduction in inter-hemispherical connectivity specific to autism 
(Hardan et al., 2009). Investigations using fMRI placed the causes for poor connectivity in 
the frontal insula, the superior temporal gyrus, the primary sensorimotor cortex, the lateral 
inferior premotor cortex and the superior parietal lobe (Anderson J.S. et al., 2010). The 
aforementioned areas are associated with social interaction management, social intelligence, 
new stimulus identification, sound processing and language linking, fine and gross motor 
activities, thereby encompassing all areas damaged by autism.  
Specific modifications in verbal communication in autism spectrum disorders incriminate 
the reduced volume of grey matter in the Broca area (where the primary motor complex is 
responsible for talking motions in the left hemisphere), considering the fact that insufficient 
neural connectivity between the Wernicke and Broca areas lead to difficulties in lexical and 
semantic processing (Yamasaki et al., 2010). The comprehension and elaboration of language 
also depends, however, on auditory sensorial integration, which serves to perceive and 
analyze sound patterns. In the Knaus et al. study, linguistic scores were correlated with grey 
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matter deficits found in frontal and temporal lobes, autistic subjects manifesting a typical 
lateralization of language (Knaus et al., 2010).  
Temporal auditory associative areas, where mono- and multimodal auditory sensor 
integration crosses, are involved in the transfer of information to the internal structures of 
the limbic and frontoparietal integration systems. By measuring cerebral blood flow using 
high resolution PET as well as high resolution SPECT, the superior temporal region of the 
autistic child’s brain was shown to have bilaterally localized hypoperfusions in the superior 
temporal gyrus and superior temporal sulcus, centered on the multimodal associative 
temporal cortex and auditory associative areas (Boddaert & Zilbovicius, 2002; Ohnishi et al., 
2000; Zilbovicius et al., 2000). This hypoperfusion was presumed to impair the transfer of 
auditory information and social perception (eye contact and facial expression), relational 
difficulties characteristic of autistic children. Ulterior studies, which undertook a 
neurofunctional perspective, reported diminished responses to auditory stimuli (Gomot et 
al., 2006) and visual stimuli (Bölte et al., 2008), along with hemodynamic modifications 
(Zilbovicius et al., 2006). The autistic brain reacts faintly to stimuli variations, a fact which 
agrees with some of the basic diagnosis criteria, such as a reduced interest for all 
surroundings, resistance to change and stereotypical activities.  
Admitting that a diminished neural connectivity, due to an excess of white matter, and some 
cerebral area hypoperfusions are responsible for the functional afflictions specific to autism, 
it would be expected that a normalization of the blood flow would improve subject 
behavior. Positive developments as concerning hyperactivity, irritability, stereotyping as 
well as improvements in verbal communication were observed during prolonged periods of 
pathological fever, presumably responsible for an increased flow of blood to the cortex 
(Curran et al., 2007). Hyperbaric oxygen therapy (HBOT), as proposed by Rossignol 
(Rossignol & Rossignol, 2006) also registered temporary improvements for autistic behavior 
(Chungpaibulpatana et al., 2008), oxygen supplementation techniques being well known 
also for their anti-inflammatory effects and their ability to regulate tissue perfusion and 
reduce oxidative stress.  
Grey matter is not only present in reduced volume in the autistic brain, but also badly 
distributed, as it is found in a thin layer in cerebral areas associated with socialization and 
all that which it entails: audio-visual and olfactory stimuli processing, face recognition, 
imitation and language (Hadjikhani et al., 2006). This situation corresponds to the mirror 
neuron system, activated in the normal brain when observing and imitating an action, and 
also considered responsible for empathy and mentalization. The mirror neuron system is 
dysfunctional in autistic subjects, as enforced by fMRI, MEG and EEG findings (Dapretto et 
al., 2006; Oberman et al., 2005; Perkins et al., 2010).  
Modern neuroimaging supports neuropsychological hypotheses concerning the causes of 
autism, i.e. the limbic system hypothesis, the weak central coherence hypothesis, the 
executive function hypothesis and the mentalization theory, but without being able to 
validate them (Bade-White et al., 2008; Joseph, 1999).  
The limbic system, presumed responsible for memory deficits that negatively impact 
communication and social interaction, was associated through imaging with structural and 
functional changes especially in the hypothalamus and amygdala, known to be correlated 
with affective and emotional behavior, sense of smell and long term memory. 
Weak central coherence, which implies a difficulty to integrate separately perceived 
elements into a whole, is associated with restricted interest and behaviour.  Poor central 
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coherence may be supported by a disproportion between white and grey matter and 
diminished neural connectivity but, considering the fact that the central coherence 
mechanism is postulated rather than demonstrated, imagistic information such as activity 
lateralization in the autistic brain and predominant involvement of the left hemisphere may 
be admitted as atypical, compensatory connections (Pierce et al., 2001).  
The executive function hypothesis, which concerns intelligence and flexibility when 
establishing priorities, is associated with the prefrontal cortex and, especially, the dorso-
lateral areas.  It has been proven that lesions in the aforementioned areas substantially 
impair executive functions, with imagistic evidence available (Levin & Hanten, 2005). In the 
case of autism, executive dysfunction manifests in the absence of lesions and exhibits 
heterogeneous cortically distribution, associable with cyto-architectural defects and/or 
atypical connectivity (Gilbert et al., 2008).  
To oppose the executive dysfunction and weak central coherence hypotheses, which aim to 
explain obsessive, repetitive autistic behavior as a blockage in information processing 
resulting from neuroanatomical and neurofunctional causes, Baron-Cohen et al. (Baron-
Cohen et al, 2009) suggest repetitiveness as a consequence of hyper-systematization. This 
aspect, remarkable in gifted high-functioning autism, is associated with sensory 
hypersensitivity which favors an exceptional perception of visual, auditory and tactile 
details and may be due to a special type of informational processing, correlated with various 
neurotransmitters through modifications in receptor density and sensitivity or 
inhibition/stimulation mechanisms. 
The mentalization theory concerns one’s capacity to understand another’s thoughts, 
engaging intention, visual contact and emotional communication. The existence of 
deficiencies in empathy and mentalization, associated with autism using psychological tests 
(Baron-Cohen, 1985), was endorsed by functional imaging, which revealed reduced activity 
in mirror neurons when recognizing a motor act preformed by another (Iacoboni & 
Dapretto, 2006). Admitting that mentalization is more than imitation, the same imagistic 
tests performed when intentionality was separated from the motor act (why-use vs. why-
place), showed that autistic patients recognize the intention behind an action but can not 
anticipate the action using the motions that make it up (Boria et al., 2009). Therefore, 
mentalization theory can not be limited to the incrimination of mirror neurons, as these 
seem to be included into an extended cortical motor system (Rizzolatti & Fabbri-Destro, 
2010). Probable causes for this system’s malfunctions are presumed to also be neural 
connectivity defects and white substance distribution.  
Imaging, along with specific marker neurochemicals, helped detect areas activated by some 
cerebrally distributed hormones, impossible to dose in vivo. Thusly, in the presence of a 
marked substitute of tryptophane, PET revealed reduced serotonin activity in the thalamus 
and frontal cortex (Chugani et al., 1999). By analyzing active serotonin and dopamine 
transport in the high-functioning autistic brain through a combination of MRI and PET, a 
significant decrease in serotonin distribution volumes was noticed throughout the brain, 
along with a volume increase for dopamine, in the medial frontal area covering the orbital-
frontal complex (Nakamura et al., 2010). Serotonin deficiencies in the thalamus were in this 
case associated with repetitive/obsessive manifestations of autism.  
MEG, another modern imagistic technique, proved to be much more sensitive, compared to 
EEG, in detecting forms of epilepsy, and contributed to the reevaluation of the frequency of 
these being  associated with autism (Lewine et al., 1999). 
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3. Biomarkers 
Clinical laboratory tests aim to reveal measurable parameter variations in blood, urine, CSF 
or tissue samples, suggesting possibly altered metabolic processes in patients suffering from 
autism spectrum disorders. 
Anemia, revealed by blood tests and iron and transferrin level assessments, support the 
hypothesis of cerebral tissue hypoxia and are frequently associated with autism spectrum 
disorders. It is believed that anemia has an irrevocably negative effect on intellectual 
function, especially when it occurs in pre-, peri- and postnatal life, even if hemoglobin levels 
subsequently normalize (Hurtado et al., 1999). Anemia tends to be chronic in autism 
spectrum disorders and is usually correlated with iron (Latif et al., 2002), folate (Moretti et 
al., 2005), and possibly ferritin (Dosman et al., 2007), transferrin and associated receptor 
deficiencies (Chauhan et al., 2004).  
Common iron deficits may be due to insufficient food intake or absorption problems caused 
by the various gastrointestinal diseases that may accompany autism. A significant 
competitor to iron absorption from food is lead, classified as a neurotoxic environmental 
pollutant. Studies suggest that intoxication may occur even in pre- or postnatal periods, lead 
being delivered to the child through the mother’s blood or milk (Gulson et al., 1998). 
Research has yet to accurately identify the origin of the lead or its role in autism spectrum 
disorders. 
Iron deficits were also associated with non-alimentary consumption (pica), sometimes 
apparent in autism spectrum disorders (Barton et al., 2010). 
Due to its ability to easily modify its oxidation state, iron participates in a large number of 
metabolic reactions, is included in hemoprotein structures and acts as an enzyme co-factor. 
As a component of hem, iron bound in hemoproteins takes part in vital metabolic reactions, 
such as oxygen transportation and storage (hemoglobin, mioglobin, neuroglobin), electron 
transfer in the respiratory chain and energy generation in the mitochondria (cytochromes b 
and c) and is a component of catalases, peroxidases and hemothyolate proteins (NO 
synthetase, P450 proteins/cytochromes), which act to bind carbon monoxide, nitrogen 
monoxide and produce free radical oxygen. Qualitative or quantitative anomalies in these 
proteins, together with specific cognitive process impairments led to the hypothesis that 
metabolic causes may be behind autism, among these tissular hypoxia, mitochondrial 
function damage and oxidative stress. 
Iron deficits associated with low hemoglobin levels explain the reduced levels of 
transported oxygen and plead for the cerebral hypo-oxygenation theory. However, there 
were cases when iron deficiencies accompany cognitive impairments without the presence 
of anemia, the cause of such occurrences being unknown (Hulthén, 2003). Recently 
discovered hemoprotein, neuroglobin, (Burmester et al., 2000), was attributed a 
neuroprotective role in cases of hypoxia and also a regulatory function for G-protein 
signaling systems (Wakasugi et al., 2005), but no related studies have yet been undertaken in 
autism spectrum disorders.  
On the other hand, iron deficiencies do not only reflect low hemoglobin, iron being also well 
distributed in tissues. A recent study (Fukunaga et al., 2010), used immunofluorescence to 
prove that iron bound in ferritine and basic myelinic proteins is non-uniformly distributed 
between cortical layers, a fact that may be interpreted as the quality of contrast on MRI 
imagery. Iron deposits were frequently identified in collocation with myelin. Considering 
the predominantly lipoidic structure of the white matter, such positioning might suggest 
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iron placement is opportune for insertion, via cytochrome P450, into the biosynthesis of 
cholesterol and other myelinic lipids that envelop the nervous fiber. Ferritin, in its two 
forms, (H and L), its adequately placed receptors and its different expressions in microglia 
and oligodendrocytes (Sammarco et al., 2008) might play an as yet undeciphered part in 
myelin regularization, impaired in autism. Considering the excessive white matter synthesis 
in the early years of an autistic child’s life and the frequency of anemia in the same period, 
Hay et al. (Hay et al., 2007) performed a study on normal children of the same age group in 
order to assess the quantity of transferring receptors. Receptor concentrations proved to 
vary, dropping in the first two years of life, but being higher in boys ever in intrauterine life, 
possibly as an influence of testosterone.  
Excessive testosterone in the womb has also been incriminated, based on typical 
psychological differences between the sexes as a cause of autism, in what was called the 
“extreme male brain theory” forwarded by Baron-Cohen in 2002. This theory places autistic 
behavior in the male extremity of a human behavior curve built upon two criteria: 
systematization (as a mark of masculinity) and empathy (as a mark of femininity). In this 
theory, testosterone is the only hormone made responsible for sexual dimorphism. Excessive 
testosterone, infiltrated prenatally, has supposedly exacerbated systematic capabilities, as 
well as dramatically reduced empathy, thereby creating an extremely masculine individual. 
At the same time, increased levels of fetal testosterone may lead to more dramatic behavior 
alterations within the male population, thus justifying the predominance of autism in males 
(sex ratio 4:1). The validity of this theory is still to be demonstrated, with large scale future 
experiments aiming to clarify the role of fetal testosterone in the delimitation between 
normal and pathological psychoneurological development. The few studies hitherto carried 
out used radioimmunochemical methods to evaluate fetal testosterone in the amniotic fluid 
(Auyeung et al., 2009; Chura et al., 2010).  
The “extreme male brain” theory is not the only one to place forward a hormonal cause to 
autism. More and more studies link autism-specific behavior alterations with levels of 
hormones derived from aminoacids (melatonin, serotonin, adrenalin/epinephrine, 
dopamine, noradrenalin/norepinephrine, GABA) or neuropeptides with hormonal activity 
(arginine vasopressin/ADH, oxytocin), making up the foundation of the hypothesis that 
autism is rooted in neuropsychoendocrinology.  
Serum half-life for some hormones can be very low, so that measuring them in biological 
fluids is difficult and subject to operator bias.  
Hormones derived from amino acids are biosynthesized by oxidizing enzymes with iron 
cofactors. Identifying hormonal deficiencies linked to altered psycho-social behavior in 
autism may also correlate with the low iron levels. 
Tryptophane 5-monooxygenase (TPH) is part of the tryptophane metabolism enzyme chain 
and generates precursors for serotonin and melatonin. Serotonin, which occurs cerebrally as 
well as periferically (more than 95%), is excreted as 5-hydroxy-indolil-acetic acid (5-HIAA). 
Serotonin concentrations may be measured directly or assessed by measuring its metabolite in 
spinal fluid or blood and urine, taking into account the fact that significant differences exist 
between periferical and cerebral media. Central serotonin deficiencies have been metabolically 
associated with autism using neuro-pharmacological methods. Prenatal stress induced by 
serotonin enhancing drugs, such as valproic acid, was associated with serotonergic neuron 
damage and is considered to be a potential cause of serotonin deficiencies in autism (Miyazaki 
et al., 2005). Low serotonin may explain the panic, anxiety, (auto)aggression as well as the 
repetitive/obsessive activities manifested in some forms of autistic behavior.  
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Tyrozine-3-monooxigenase (TH) is involved in the synthesis of L-dihydroxyphenylalanin 
(L-DOPA), a precursor of dopamine and, consequently, of noradrenaline and adrenaline. 
Phenylalanine-4-monooxygenase (PAH) participates in the L-phenylalanine metabolism as a 
precursor of tyrosine and, consequently, chatecholamines.  
Dopamine is a neuromediator stored in the hypothalamus, tightly linked to the central 
reward system, which associates certain actions with a sense of pleasure, and controls the 
actions necessary to fulfill the action. Through its responding to the novelty stimulus, 
dopamine is also involved in the learning by experience process. Levels of dopamine may be 
assessed by measuring the concentration of its metabolite, homovanilic acid (HVA). In some 
cases, autism was pharmacologically associated with elevated levels of dopamine, as its 
agonists actually accentuated stereotypical behavior and increased aggression, while 
dopamine antagonists produced slight alleviations of such behavior (Tsai, 1999).  
From the perspective of hormonal activity, repetitive/stereotypical behavior may be 
regarded as an obstinate search for an unattained pleasure (lack of serotonin). However, the 
subject anticipates satisfaction and understands the motric details that should lead up to it, 
and therefore performs them repeatedly (high dopamine levels). This interpretation is 
consistent with the hyper-systemizing hypothesis, but may also explain short-term memory 
impairment which prevents learning and obtaining ultimate satisfaction from goal 
achievement. 
The appliance of immunohistochemistry on animal brains lead to the observation that 
dopamine, as well as one of its receptors (D1), accentuates the development of GABA 
neurons, which play an important role in neuro-epithelial cell growth modulation, neuron 
migration and circuit forming (Crandall et al., 2007). The release of GABA in the synaptic 
space is equivalent to a cease of information transmission and depends on specific receptors, 
included in the neural membrane. One of these receptors (GABAA) is inhibited by zinc ions, 
located cerebrally using fluoro- and radiomarkers (Smart et al., 2004). When released into 
the synaptic space, zinc ions can block some post-synaptic glutamate receptors (NMDA 
type), thereby becoming a neuromodulator. Physiological zinc concentrations take on 
neuroprotective and anticonvulsive roles. In zinc deficiencies, excessive glutamate may lead 
to prolonged neural hyperexcitability, displayed through epileptic seizures (Takeda et al., 
2003), often associated with autism spectrum disorders. Additionally, proton magnetic 
resonance imaging found elevated glutamate levels in the hippocampus and amygdala 
(Page et al., 2006). Zinc pools mainly in the hippocampus and amygdala, areas tightly linked 
to autism by imaging (Szewczyk et al., 2010).  
GABA neurons are close to acetylcholine receptors, part of the cholinergic system, which 
coordinate autonomous functions using sympathetic and parasympathetic pathways. Upon 
stimulation of the acetylcholine receptor, the dopaminergic system was found to react by 
releasing GABA (Lester et al., 2010). Therefore, cognitive process alteration may reside in 
the dopaminergic system (neuroanatomical modifications, zinc metabolism, iron 
deficiencies) as well as in the cholinergic system (Youdim, 2008). This logic justifies 
autonomous function impairments that accompany autism, such as afflictions of the 
digestive tract (difficult nutritional uptake and swallowing, defective transit and vomiting), 
arrhythmias, fever episodes, altered pain perception, problems with urination, anxiety, 
emotional lability and impaired socialization. 
Various numbers of studies were carried out on L-DOPA, adrenalin and noradrenalin and 
did not reveal significant correlations with autism.  
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Low levels of melatonin link to frequent sleep abnormalities registered in autism (Melke et 
al., 2008). Melatonin uptake improves nightly sleep for autistic children as well as for other 
categories of people struggling with circadian rhythms. Circadian preferences may be 
associated with autistic hyper-sensitivity to auditory or other disruptive environmental 
stimuli, unnoticeable to normal people.  
Neuropeptides involved in neural signaling, influence cerebral activity and are linked to 
complex processes such as learning and memory, essential to create personality and 
adaptability. Studies suggest arginine vasopressin and oxytocin may influence neural 
connections related to individuals relation forming  therefore, recently come important for 
autism correlations. 
Arginine vasopressin is synthesized in the hypothalamus, stored in the posterior 
hypophysis and released in the supraoptical nuclei according to the circadian rhythm. 
Oxytocin is secreted by the hypophysis and also acts remotely, like arginine vasopressin, its 
action modulated by receptors. Animal studies showed that hormonal action completion 
depends both on the concentration of neuropeptides and respective receptor density. In 
1987, Le Moal and Dantzer carried out studies on mice to prove associative behavioral 
differences correlate with antidiuretic hormone levels. Excess arginine vasopressin was 
linked with associative relation stability, i.e. monogamy.  Winslow et al. studies associated 
arginine vasopressin with male voice modulations in a social context, in some species of 
monkeys, and also with increases in motor activity upon central hormone administration 
(Winslow & Insel 1991; Winslow et al., 1993). Increased levels of arginine vasopressin in the 
hypothalamus was recorded post-partum, in both males and females of certain rodent 
families, hinting to the hormone’s role in affiliation, attachment and sexual and parental 
behavior manifestations (Wang et al., 2000). Increased levels of ADH found in human CSF 
and murine brains were correlated with aggression as well as with social memory. Autistic 
subjects showed increased levels of arginine vasopressin (Boso et al., 2007) and reduced 
levels of oxytocin (Modahl et al., 1998). Resulting anxiety was relieved by oxytocin nasal 
spray administration, which appeared to also contribute to an improvement in verbal and 
affective communication. Ferguson et al. hypothesized arginine vasopressin involvement in 
the consolidation (rather than acquisition) of social memory (Ferguson et al., 2002).  All 
these studies revealed a more predominant influence of vasopressin in males, the equivalent 
of which being oxytocin in females (Lim & Young, 2006). Protective behavior towards 
offspring and the pursuit of social integration (“tend-and-befriend”) are linked to oxytocin 
and the female sex, while the male is attributed adaptive-aggressive („fight-or-flight”) 
behavior. Specific receptor distribution was found to be influenced by steroid sexual 
hormones and differentiated by sex and displayed level of affinitive behavior (Hammock et 
al., 2006). Some dopamine receptors are laminar distributed with oxytocin receptors, making 
their interaction more likely in social attachment behavior, while arginine vasopressin 
receptors are disfavored (Smeltzer et al., 2006).  
The hypothetic hormonal cause to autism intersects with the oxidative stress hypothesis 
when it comes to glutamate exocytotoxicity. Glutamate release into the extracelluar space 
leads to increased intracytoplasmatic calcium ion levels but, when concentrations above 10-5 
M are reached, calcium is pumped through membrane transport proteins into the interior of 
mitochondria (Krauss, 2003), where it triggers metabolism through matrix dehydrogenases. 
Besides contributing to ATP production, the shift of iron state of oxidation generates free 
radicals that are detoxified, in physiological conditions, by the mitochondrial antioxidation 
systems: superoxid dismutase, catalase, glutathione peroxidase, glutathione reductase – 
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enzymes lacking in autism (Yorbik et al., 2002). Given time and non-physiological 
conditions, reactive oxygen species generated cause mitochondrial damage, decreased ATP 
production and, eventually, apoptosis. Considering the fact that apoptosis is integral to 
development, morphogenesis and homeostasis, as it removes excessive or irrecoverable cells 
from the cellular cycle arrest, it is admissible that endogenous and/or exogenous stress 
factors in prenatal, postnatal periods and early years influence cerebral architecture and 
development, vulnerable to oxidative stress.  
Some substances, such as lactate, piruvate, aspartate, found in excess levels in blood and 
urine also plead for the hypothesis that mitochondrial functions may be impaired (Giulivi et 
al., 2010; Weissmann et al., 2008). Lactate, which appears in blood as a secondary product of 
anaerobic glycolysis, points to tissular hypoxia caused by mitochondrial oxidative 
phosphorilation impairment and, in association with anion gaps, may lead to metabolic 
acidosis, encountered in some cases of autism (Lombardi, 1998). In some patients, MRI and 
PET scans showed diminished rates of glucose metabolization in the striatum and thalamus 
(Haznedar et al., 2006). Lactatemia also registers as a side effect of anticonvulsive treatment, 
administered when autism is aggravated by epilepsy (Willmore et al., 2006).  
Oxidative stress occurs when antioxidant capacity is overwhelmed, either because 
insufficient free radical scavenging enzymes are produced, because glutathione levels drop, 
or there are excessive reactive oxygen species (ROS) induced by exogenous factors (e.g. toxic 
heavy metals such as lead or mercury). 
In antioxidant enzyme deficits, mitochondrial permeability transition increases in astrocytes 
for an endogenous toxic, difficult to annihilate: ammonia (Seyan et al., 2010). Excessive 
ammonia, found in some autistic subjects, represents the consequence of urea cycle defects 
(ornitin transcarbamilase/OTC, argininosuccinic acid/ASA syntethase deficiencies) or is a 
side-effect of anticonvulsive medication. Chauhan et al. (2004) associates oxidative stress in 
autism with low transferrin and plasmatic ceruloplasmin coupled with accentuated lipid 
peroxidation. Normal zinc levels would not allow excessive lipid peroxidation but, in 
autists, zinc levels were usually found to be low. Zinc deficiencies may also generate 
shortages of superoxide dismutase (a Cu-Zn enzyme).  
Glutathione insufficiencies were revealed by HPLC in a study carried out on autistic 
subjects by James et al. and were associated (via homocystein) with decreased methyonin 
cycle turnover (James et al., 2004). This, in turn, implies a diminished synthesis of S-
adenosyl methyonin (SAM), which is required to methylate proteins and DNA (Waterlow, 
2006). The redox/methylation hypothesis (Deth et al., 2008), put forward as an expression of 
the response to environmental stress factors, is, as yet, insufficiently supported by ample 
genetic studies to investigate methylation profiles in autism and their roles in neural 
network synchronization.  
The possibility exists that this scenario correlates with various types of anemia encountered 
in autism either through folate deficiencies (cysteine is obtained from homocysteine by 
means of a folate-dependent enzyme) or through the iron lost by high urinary porphyrin 
elimination, as a result of oxidative stress induced by heavy metal poisoning (Geier et al., 
2009). Urinary porphyrin  concentrations are comparable to those found in adults exposed 
to mercury poisoning, in which the presence of an atypical porphyrin in urine 
(precoproporphyrin) is associated with an inhibitory effect of mercury on kidney 
uroporphyrinogen decarboxilase (Woods et al., 2010). Since most investigated subjects did 
not have significant (organic/inorganic) mercury levels, the mechanism of this disturbance 
in the hemoglobin metabolism in autism is still unclear. 
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Glutathione deficiencies also correlate with gastrointestinal dysfunctions that often 
accompany autism. Oxidative stress is emphasized upon intake of a large gamut of foods, 
while the intestinal wall opposes the passage of toxic agents into the body. The maintenance 
of high levels of antioxidants (glutathione, vitamin C, tocopherols) and also of antioxidant 
enzymes represents two cellular integrity defense mechanisms. Should these fail, the 
intestinal cell is directed towards apoptosis or necrosis. (Aw, 1999). 
A preliminary response to oxidative stress is white cell proliferation and subsequent signal 
cascade, followed by neutrophyle infiltration into intestinal cells, through diapedesis. 
Cellular migration is associated with an increased synthesis of proinflammatory cytokines 
(e.g.: IL-1ǃ, IL-6, IL-8 and TNF-ǂ), which act as a “first response” in acute inflammatory 
reactions. Anti-inflammatory response is quick to appear, as evident through IL-4, IL-13 and 
TGF-ǃ cytokine synthesis. Ingesting food high in Maillard reaction final products activates 
macrophages and spreads intestinal inflammation to the entire organism (Georgescu, 2005; 
Muscat, 2007). Cytokines, as well as free radicals, activate the intranuclear translocation of 
the NF-kB transcription factor which, when bound to DNA, modulates numerous genes 
involved in inflammation and immunity. Intestinal mucose inflammation, histologically 
investigated through biopsies, was associated in autism with increased TNF-ǂ, IL-2 and IL-4 
in the duodenum and elevated TNF-ǂ in the colon, with a more pronounced 
proinflammatory activity in subjects whose diets included casein and gluten (Ashwood et 
al., 2004). Proinflammatory (IL-1ǃ, IL-8 and especially TNF- ǂ) and anti-inflammatory (IL-4, 
IL-10, IL-12) cytokines, found in plasma, CSF, culture cells and in post-mortem cerebral tissue 
were found to be in high concentrations in autism (Ashwood et al., 2006; Chez et al., 2007). It 
is noteworthy that cytokines can cross the blood-brain barrier, affect neuron function and 
accentuate metabolism for hormones such as noradrenalin, dopamine and serotonin 
(Pickering et al., 2005; Zhao B. & Schwartz, 1998). Some cytokines were associated with 
autism specific aspects such as sleep, cognitive function abnormalities or depression (IL-2, 
TNF-ǂ) (Larson, 2002). Additionally, anti-cerebral peptide autoantibodies (antimyelin, anti-
Purkinje cells and anti-caudate nucleus) were identified by Western blots in serum, which 
speaks of a vulnerability of the blood brain barrier in autism (Singer et al., 2006). On the 
other hand, plasma harvested from autistic children’s mothers was found to contain 
antibodies to human fetal brain of approximately 37 kD and 73 kD, which may represent a 
possible contribution of the maternal immune system to autism etiology (Braunschweig et 
al, 2008). Since oxidative stress and/or immunological vulnerability is manifested in autistic 
children from a very early age, it is legitimate to suspect that these may be consequences of 
environmental conditions in the mother’s womb (Dietert & Dietert, 2008; Kinney et al, 2008). 
4. Genetic and molecular testing 
Any attempt to evaluate a diagnosis of autism can not escape genetic and molecular 
investigation. The heterogeneity of the psychological, morphological and functional aspects 
which contributed to the classification of the forms of autism undoubtedly has a genetic 
background that is currently being investigated, each organism being in fact an expression 
of its genetic pattern adapting to its environment. It is presumed that autism spectrum 
disorders have a major genetic component, with a complex and as yet undiscovered means 
of transmission. Twin studies revealed a rate of correlation of between 60 and 90% for 
monozygote twins and of 0 to 10% for dizygote twins (Bailey et al., 1995). 
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It is unlikely, given the great diversity of symptoms and particularities of autism, that a 
single gene may mutate with pleiotropic effects. On the other hand, the same reasons make 
it very likely that the diverse manifestations may be due to environmental factors, which 
occur with various intensities and cause different responses, according to genetically 
dictated, individual tolerances. All things considered, autism is outlined as a complex 
manifestation, posing great difficulties when it comes to pinpointing its origins.  
Identification of candidate genes was performed using methodology both direct and 
indirect (in the case of secondary autism, associated with other syndromes characterized by 
neuropsychiatric afflictions). The discovery of genes linked to Rett syndrome (MECP2), 
Joubert syndrome (AHI1), neurofibromatosis type 1 (NF1), tuberous sclerosis (TSC1) and 
fragile-X syndrome (FMR1) allowed for differential diagnoses for these illnesses and opened 
the door to further genetic association for autism. 
The direct approach to identifying the genetic components of autism used three categories 
of methods: chromosomal analysis, linkage and association studies and, respectively, 
candidate gene direct analysis. The numerous and various outcomes called for the 
development of specific databases. The Centre for Applied Genomics, established in 2004, in 
Toronto, maintains the Autism Chromosome Rearrangement Database, which comprises both 
cytogenetic as well as array comparative genomic hybridization/aCGH data. The Autism 
Genetic Database (AGD), established in 2009 at the University of Kansas, offers a generous list 
of autism-susceptible copy-number variations/CNVs (743) and genes (243), as well as a 
series of fragile sites (120) and non-coding RNA genes which act as regulators and are 
intensely expressed in the nervous system (more than 650.000) (Matuszek & Talabizadeh, 
2009). Also, the Stritch School of Medicine database from the Loyola University of Chicago, 
offers an eloquent mapping of candidate genes (238), CNVs, SNP polymorphisms and 
microinsertion/deletion sites linked to autism (Autism Candidate Gene Map (ACGMAP) 
Database). 
Structural variations, recorded through cariotyping and SNP polymorphism analysis, are 
found in many chromosomal sites throughout the haploid genome: 1p, 1q, 2q, 3p, 3q, 4p, 4q, 
5p, 5q, 6q, 7q, 8q, 11p, 12p, 13q, 15q, 16p, 17q, 19p, 19q, Xp şi Xq (Xu et al., 2004). The most 
frequent rearrangements appear in 2p, 7p (translocations in the 7q22-q33 regions), 15q 
(duplications in the 15q11-q13 regions), 16p and X. Studies suggested that the modifications 
encountered are most often hereditary, but may also appear spontaneously – as previously 
documented or indeed, as novel forms – therefore demanding the taking into account of 
additional risk factors, whether genetic, epigenetic or environmental. 
The loci that presented high CNVs comprise genes involved in neural development and 
synaptic activity, genes associated with oxidative processes, immunity or transcriptional 
processes, genes encoding various metabolic pathway enzymes, hormones and receptors, 
zones associated with mental retardation (15q24 and 16p11.2) as well as other genes with 
modified expressions. Locus 16p11.2 stood out with the highest CNVs frequency (1%), 
correspondent to structural modifications that were mostly microdeletions and 
microduplications (Marshall et al., 2008; Weiss et al., 2008). 
The most sought-after candidate genes were the ones most likely to be involved in central 
synaptic formation and modeling, cell adhesion and position and neural migration, such as: 
NLGN1 (3q26.31), NLGN3 (Xq13.1), X-linked NLGN4 (Xp22.32/33) and Y-linked NLGN4 
(Yq11.221)/encoding for neuroligins, SHANK3 (22q13.3)/ankirin, PCDH9 
(13q21.32)/protocadherin, NRXN1 (2p16.3), CNTNAP2 (7q35)/neurexins, RELN 
(7q22)/reelin (Glessner et al., 2009). 
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After a study which looked at a great number of families with autism, Yonan et al. attribute 
significance to gene locus SLC6A4 (17q11.2) around the sequence exhibiting the maximum 
LOD score for 17q chromosome linkage (Yonan et al., 2003).  The gene codifies a membrane 
protein for serotonin transport which carries the neurohormone from synaptic spaces into 
presynaptic neurons and which correlates with aggressive behavior and attention deficits. 
Deciphering the ever more important hormone contribution to psycho-behavioral modelling 
triggered a reorientation of studies towards genes encoding hormones, neuropeptides and 
membrane receptor cells like: GABRA3 (Xq28), GABRB3 (15q11.2-q12), GABBR2 (9q22.1-
q22.3)/encoding GABA receptor-proteins, which participate in the inhibition of excitation 
transmission, AVPR1A (12q14.2)/encoding the 1a arginine vasopressin receptor, OXT 
(20p13)/coding for oxytocin and neurophyzine 1, OXTR (3p25.3)/coding for oxytocin 
receptor, DRD1 and 3 (5q35 and 3q13.3)/coding for dopamine receptors (Anderson B.M. et 
al., 2008; Harony & Wagner, 2010; Muhler et al., 2004; Yirmiya et al., 2006).  
Some genes from autism linked-CNVs have metabolically correlated expressions, which 
amplify their candidate gene status.  For example, 10 genes encode proteins from the 
phosphatidylinositol signal pathway and the glutamatergic synapse which are correlated 
through phosphatidylinositol-3-OH kinase (Cuscó et al., 2009). Genes like UBE3A (15q11.2), 
PARK2 (6q25.2-q27), RFWD2 (1q25.1-q25.2) and FBXO40 (3q13.33), which encode similar 
function proteins (ubiquitin protein ligases), are associated with ubiquitin degradation as 
well as neuron cell adhesion (Glessner et al., 2009). Also, the SLC6A4 gene, involved in 
serotonin metabolic and signal pathways, was associated, by epistasis, with the ITGB3 
(17q21.32) gene, encoding an integrin (Coutinho et al., 2007). An interesting correlation was 
found in astrocytes, between a V1a arginine vasopressin receptor antagonist and the 
hormone’s anti-inflammatory and immunomodulating activities, by suppressing gene 
expression for IL-1ǂ, IL-1ǃ, IL-2 and TNF-ǂ cytokines using a CREB transcription factor-
dependant mechanism (Zhao L. & Brinton, 2004).  The CREB1 (2q34), along with SHANK3, 
DLG3 (Xq13.1) and DLG4 (17p13.1) genes, were also studied in association with memory 
and learning processes, afflicted by autism. 
As deciphering genetic mechanisms is still a distant goal, suspicion falls, for the moment on 
genes like FOXP2 (7q31), involved, in embryogenesis, in the developing cerebral regions 
associated with language, CNTNAP2 (7q35-q36), encoding a neurexin-type protein or 
DYX1C1 (15q21.3), which gives susceptibility to dyslexia. 
The contribution of these genes to autism remains disputed, as association frequencies are 
low. Without any firm links between identified genetic modifications and autism, more 
recent studies aimed to characterize polymorphisms in regulatory zones – an undertake 
made easier by the completion of human genome sequencing. Also, animal model studies 
additionally augment data acquisition. An eloquent example is the analysis of AVPR1A 
gene promoter polymorphisms: by observing affiliative behavior in mice, it was concluded 
that arginine vasopressin levels are not the only factors that influence affiliation, and that 
the distribution of membrane hormone receptors, encoded by the AVPR1A gene, also plays 
a part. The three polymorphisms identified in the gene promoter were presumed to 
influence gene expression and, in consequence, were associated with types of affiliative 
behavior. Considering the genetic similarities between mice and humans, these 
polymorphisms were studied in connection with autism, which exhibits a powerful 
alteration of affiliative impulses. Studies revealed a transmission imbalance of RS1 and RS3 
polymorphisms linked to autism (Kim et al., 2002), associated with willing socialization 
(Yirmiya et al., 2006) and prepulse inhibition in auditory stimulus response as stress-
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adaptive reaction (Levin et al., 2009). Another pathway for research are the epigenetic 
studies, from among which global methylation profile investigation revealed significant 
modifications in two genes: RORA (15q22.2) and BCL-2 (18q21.3), whose expressions are 
subdued in the autistic brain (Nguyen et al., 2010). A recent study by Sarachana et al. 
stresses the importance of RORA as a candidate gene, because of the correlation between its 
expression and testosterone levels. RORA-encoded protein synthesis is stimulated by female 
hormones and inhibited by male ones. In the autistic brain, besides reduced RORA-protein 
levels, low aromatase levels were also found (Sarachana et al., 2011). Aromatase is an 
enzyme from the P450 cytochrome family which acts to maintain an elevated testosterone 
level. The molecular mechanism proposed by this study might explain the elevated 
frequency of autism among the male population and also add an argument to support 
Baron-Cohen’s “extreme male brain” theory.  
5. Conclusion  
There is no concrete data on autism before Kanner (1943). For years, autism was considered 
a rare illness consisting of emotional contact impairments in children. As psychologists and 
psychiatrists looked more closely into the matter, autism was scrutinized, classified and 
linked with a triad of modified behavioral aspects involving socialization, language and 
obsessive/repetitive actions. During the last 30-odd years, the frequency of autism began to 
rise dramatically, up to alarming levels in some countries. Whatever the cause of this 
increase (better information dissemination among the medical community and the general 
population and/or a real increase in the number of afflicted children) autism was boosted to 
the peak of modern research interest and major resources were devoted to discovering the 
underlying causes of this developmental disorder.  
The study of the brain, as the material basis for psychic processes, emerged as a prioritized 
research direction and the discovery of new means of imagistic investigation helped make a 
significant leap for normal and pathological cerebral anatomy and function understanding. 
Studies of the autistic brain converge to a general unitary conclusion of cerebral spatial and 
temporal development impairment. The defining elements for autistic anatomo-functional 
defects are excessive white substance and low neural connectivity, which may be linked to 
anomalous neuron migration, axon and synaptic development, neural impulse transmission. 
Although modifications were described in many areas of the brain, the most frequent 
associations lead to the corpus callosum, thalamus, amygdala and cerebellum. Considering 
the behavioral triad afflicted by autism, deficient socialization was linked to the 
orbitofrontal, anterior cingulate and posterior parietal cortexes, the fusiform and inferior 
frontal gyruses, the amygdala and mirror neurons, impaired communication was traced to 
the Broca area, the superior temporal sulcus, the thalamus and the basal ganglia, while 
repetitive behavior was found to be reflected in the orbitofrontal and anterior cingulated 
cortexes, the basal ganglia ant the thalamus. For temporal anomalies, it remains to be said if 
excessive brain dimensions recorded in the early years of life is caused by prolonged 
neurogenesis or glial cell overproduction, perhaps in conjunction with delayed neuron 
death (Verhoeven et al., 2010). Performing neuroimagistic investigation on children with 
idiopathic autism is difficult. Functional study subjects require a former period of 
introduction and accommodation and need to exhibit a certain degree of comprehension 
and participation, therefore unavoidably implying older test subjects, which are often cited 
as “high-functioning autists” or Asperger syndrome sufferers. Moreover, correlating 
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functional imaging with psycho-behavioral studies concerning affection entails, even for 
normal individuals, a certain degree of imprecision derived from the multiple variables that 
concur in the momentary psychic status-quo. In order to obtain relevant results, all applied 
techniques require synchronization between the time that the brain responds to a stimulus 
and the time at which the response is recorded, a reason for using professional actors as a 
control group (Perreau-Linck et al., 2007). Therefore, neuroimagistic studies have not yet 
been able to tell “where” autism-specific structural and functional modifications occur in the 
brain, but are breaking new ground for general human brain exploration, cerebral stimulus 
processing and reactive response. 
Another perspective for evaluating autistic diagnoses involves investigating biochemical 
and immunological profiles. This path is however subject to limitations imposed by the 
inherent differences between the presence and/or concentration of various substances in 
blood, CSF and brain tissue as a result of blood-brain barrier activity – while under 
suspicion that even this mechanism might be modified by autism. As access to brain tissue 
for biochemical or immunological studies is restricted and spinal punctures are invasive 
procedures to which parents seldom consent, the great majority of tests have to focus on 
blood or urine, in an attempt to identify products relevant for a diagnosis.  
For patients diagnosed with autism spectrum disorders, laboratory testing indicated a series 
of very diverse blood or urine parameter alterations, which, even if associable with 
metabolic process dysfunctions, did not yield a stable marker for autism, but instead 
generated new plausible causalities materialized into theories based on the oxidative stress, 
mitochondrial, hormonal and neuro-transmission dysfunctions, signal pathway alterations, 
immune dysregulation, maternal-fetal effects or subsequent combinations thereof. 
Unfortunately, no complex study has yet to use a single large study lot with good 
representation for all types of autism in order to simultaneously check for biochemical and 
immunological anomalies otherwise fractionally identified (a metabolomic approach) such 
as: oxidative enzyme and glutathione deficiencies, metal poisoning, excess lactate and 
pyruvate, disturbances in the urea cycle, iron and zinc deficits, low levels of serotonin and 
melatonin, excessive dopamine, the arginine vasopressin/oxytocin balance, atypical 
porphyrins in urine or excessive pro- and anti-inflammatory cytokines. For the moment, test 
results show little uniformity, as the polymorphic and complex spectrum of autism 
demands a quasi-individual approach for each patient. Understanding the need for a 
systematic approach to autism, the National Institute of Health (USA) launched an 
ambitious attempt to create a national, interactive network (The Interactive Autism Network) 
to facilitate data flow. The National Database for Autism Research (NDAR), established in 
November 2010, also aids future studies by making available a wide database of reference 
imagery as well as autistic genotypes and phenotypes. It functions in close collaboration 
with the Autism Genetic Resource Exchange (AGRE), which offers DNA, cell lineages and 
serum from families with autistic children. The aforementioned institutions are also 
currently considering the future establishment of a brain tissue database.  
While biochemical and immunological analysis can not definitively answer „what” causes 
autistic behavior or „how”, neither can genetic testing indicate “who” is responsible for the 
modifications observed. Hundreds of studies sought associations between abnormal protein 
levels (structural proteins, enzymes, hormones, receptors, immunoproteins), their encoding 
genes and their corresponding regulatory regions. Results encountered the same 
inconsistencies regarding autism causality, but the amount of new data brought into 
behavioral genetics is by no means unimportant. New genomic analysis methods (aCGH) 
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point to chromosomal areas most likely to be associated with autism, which reduce gene 
selection areas, admitting that their numbers may mean to autism either the contribution of 
more than one locus, genetic heterogeneity, epigenetic effects, or the result of environmental 
influence on genetic givens.  
The evaluation of a diagnosis of autism has to arrive at answering “when?” and “how?” 
development impairment occurs on such a debilitating scale. Mental illnesses – therefore 
also autism – are regarded as multifactorial disorders. It is therefore plausible that an 
environmental factor, even in small quantities, is capable of setting in motion a series of 
molecular and cellular alterations which induce major behavioral modifications compatible 
with autism. It can be also inferred that this trigger for anatomical and functional brain 
damage penetrates the womb, where it may act upon the central nervous system throughout 
its long development, thus accounting for the permanence of the affliction. In order to reach 
the cerebral level, the presumed environmental factor, whether biological or chemical in 
origin, should be capable of crossing the open blood-brain barrier (while in uterus) or, if 
contamination occurs after the barrier has closed, to navigate it with or without inflicting 
structural changes. Some studies suggest that oxidative stress may affect blood brain barrier 
function (Lochhead et al., 2010) and others point to certain inefficiencies in the barrier itself 
in autism.  
The fact that oxidative stress is capable of influencing gene expression by modifying DNA 
methylation patterns enforces the suspicion that it plays a critical role in autism. Oxidative 
stress on the organism is maintained by heavy metals, pesticides or Maillard reaction final 
products. These are brought into the body through aliments and may exert neurotoxic 
effects even in the womb, provoke redox imbalances, alter metabolic pathways, change 
membrane permeability or cause inflammation and immunological vulnerability. Perhaps it 
is not by chance that countries that use large quantities of organo-phosphate pesticides have 
the highest frequencies of autism, considering the fact that the enzyme that breaks down 
these products, paraoxonase 1, is deficient in autism (Deth et al., 2008; Paşca et al., 2006). 
Also, career-making women, who come to consume food that is nutritionally altered by 
packaging, coloring and flavoring, develop greater risks of delivering autistic children. 
Maillard reaction products intervene, among other things, in iron and zinc complexation 
(Zhang et al., 2009) – which may explain why these ions are scarce in autistic children, even 
before birth. On the other hand, from the hormonal perspective, whether modern women 
suffer from excessive testosterone and, furthermore, whether that can be linked to autism 
via the “extreme male brain” justification remains to be proven by further, more consistent, 
studies. 
The effort to identify the cause behind autism spectrum disorders is coming more and more 
to resemble a worldwide, multifrontal assault on an impregnable labyrinthine territory. 
Current research implies an interdisciplinary approach to the complexity of the autistic 
phenomenon in order to arrive at relevant genotype-phenotype-environment correlations 
that offer a chance of early diagnosis and/or therapeutic approach.  
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